Angiotech is a Vancouver, British Columbia pharmaceutical company.
Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 21, 2017 | Series Unknown | — | 4 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Cathay Venture | — | Series Unknown |
Fung Shing Investments | — | Series Unknown |
ZQ Capital | — | Series Unknown |
China Orient Asset Management (International) Holding | — | Series Unknown |